Preoperative single-fraction stereotactic partial breast irradiation using GammaPod technology is associated with a promising ...
A tool to integrate breast cancer transcriptomic datasets could help clinicians with more accurate diagnosis and better ...
AI innovations look set to transform healthcare by facilitating precision medicine, improving diagnostic accuracy and ...
Solubility is one of those properties that are essential for the medication to have its intended effect, and yet it depends on the crystal structure assumed by the molecules in the pill or, in this ...
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical, a leader in AI-driv ...
We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Perimeter Medical ...
Healio spoke with Marvell Adams Jr., CEO of Caregiver Action Network, about how women caregivers are more likely to ...
Lunit to present 15 studies, with an unprecedented 13 accepted as oral presentations, marking a significant milestone in ...
Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative ...
AstraZeneca's SERENA-6 trial shows camizestrant plus a CDK4/6 inhibitor improves progression-free survival in HR-positive, HER2-negative breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results